HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of melatonin and stobadine on maternal and embryofoetal toxicity in rats due to intrauterine hypoxia induced by phenytoin administration.

Abstract
The aim of the present study was to test the hypothesis that the natural antioxidant melatonin (MEL) and the synthetic antioxidant stobadine (STO) could reduce the incidence of maternal and embryofoetal toxicity in rats due to intrauterine hypoxia. Chronic hypoxia was induced pharmacologically by the administration of the anticonvulsant phenytoin (PHT) during the entire period of pregnancy. PHT disturbed the normal course of pregnancy, affected reproductive parameters and increased the incidence of skeletal anomalies. MEL did not protect the PHT-induced development toxicity in rat. On the other hand, STO partially prevented PHT-induced reduction of foetal and placental weights. Administration of STO also decreased the frequency of pre- and post-implantation loss and resorptions in the PHT group. We concluded that pretreatment of pregnant rats with STO prevented to a certain extent reproductive and foetal development alterations caused by chronic intrauterine hypoxia.
AuthorsE Ujházy, M Mach, M Dubovický, J Navarová, L Soltés, I Juránek, I Brucknerová, M Zeman
JournalCentral European journal of public health (Cent Eur J Public Health) Vol. 12 Suppl Pg. S83-6 (Mar 2004) ISSN: 1210-7778 [Print] Czech Republic
PMID15141990 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticonvulsants
  • Carbolines
  • Phenytoin
  • Melatonin
  • dicarbine
Topics
  • Abnormalities, Drug-Induced
  • Analysis of Variance
  • Animals
  • Animals, Newborn
  • Anticonvulsants (toxicity)
  • Body Weight (drug effects)
  • Carbolines (pharmacology)
  • Female
  • Hypoxia (chemically induced)
  • Melatonin (pharmacology)
  • Phenytoin (toxicity)
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: